BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3096615)

  • 41. [Hereditary spherocytosis associated with Bence Jones type multiple myeloma: a case report].
    Hattori Y; Harada K
    Rinsho Ketsueki; 1988 Feb; 29(2):254-7. PubMed ID: 3133511
    [No Abstract]   [Full Text] [Related]  

  • 42. [IgG (kappa) benign monoclonal gammopathy, IgG (kappa) multiple myeloma and Bence Jones (lambda) multiple myeloma in 3 brothers].
    Unakami H; Kikuta Y; Ohnami K; Umetsu Y; Itoh K; Kumagai H; Kuroha M; Tsukamoto K; Ukai K; Komatsu M
    Nihon Naika Gakkai Zasshi; 1987 Jul; 76(7):1087-91. PubMed ID: 3681086
    [No Abstract]   [Full Text] [Related]  

  • 43. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
    Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
    Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
    [No Abstract]   [Full Text] [Related]  

  • 45. The clinical aspects of biclonal gammopathies. Review of 57 cases.
    Kyle RA; Robinson RA; Katzmann JA
    Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The determination of serum immunoglobulin concentrations on the basis of their light-chain antigenic properties.
    Eickhoff K; Heipertz R
    Clin Chim Acta; 1977 Jul; 78(2):343-9. PubMed ID: 69509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on the Bence-Jones protein--study on paraproteins detected in myeloma patients with tetrameric Bence-Jones proteins (type kappa) (author's transl)].
    Togawa A; Imamura Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):571-81. PubMed ID: 816132
    [No Abstract]   [Full Text] [Related]  

  • 48. Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma.
    Kosaka M; Iishi Y; Okagawa K; Saito S; Sugihara J; Muto Y
    Am J Clin Pathol; 1989 Jun; 91(6):639-46. PubMed ID: 2499179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
    Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
    [No Abstract]   [Full Text] [Related]  

  • 50. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Buschke's scleredema and monoclonal dysglobulinemia: apropos of 3 cases].
    Clerici T; Faure M; Chouvet B; Perrot H; Hermier C
    Dermatologica; 1983; 166(5):240-6. PubMed ID: 6409682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two Bence Jones proteins of different immunological type (light chains kappa and lambda) in a case of micromolecular myeloma.
    Sega E; Isabella F; Citro G
    Boll Ist Sieroter Milan; 1973; 52(5):436-45. PubMed ID: 4207360
    [No Abstract]   [Full Text] [Related]  

  • 53. Multiple myeloma with discordant M components in the serum and CSF.
    Dotten DA; Pruzanski W
    Arch Intern Med; 1981 Sep; 141(10):1374-6. PubMed ID: 6791605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
    Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
    Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Light chain disease and massive proteinuria.
    Lessard F; Bannon P; Lepage R; Joly JG
    Clin Chem; 1985 Mar; 31(3):475-7. PubMed ID: 3918811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytology of myeloma cells.
    Hayhoe FG; Neuman Z
    J Clin Pathol; 1976 Oct; 29(10):916-22. PubMed ID: 824323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Massive systemic amyloidosis as a sequel to Bence-Jones plasmacytoma (kappa type)].
    Stasiecki P; Uerlich M; Löffler A; Krueger GR; Strödter H; Gross R
    Internist (Berl); 1987 Oct; 28(10):689-92. PubMed ID: 3119510
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum IgA-lambda monoclonal gammopathy in a patient with immunoblastic sarcoma with IgM-kappa cell surface immunoglobulin].
    Urbano Ispizua A; Estruch Riba R; Anegón I; Gallart T; Bladé J; Urbano-Márquez A; Rozman C
    Med Clin (Barc); 1985 Mar; 84(10):405-7. PubMed ID: 3921785
    [No Abstract]   [Full Text] [Related]  

  • 59. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma.
    Hom BL
    Am J Clin Pathol; 1984 Nov; 82(5):627-9. PubMed ID: 6437210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia: an ultrastructural and immunopathologic study.
    Vital C; Vallat JM; Deminiere C; Loubet A; Leboutet MJ
    Cancer; 1982 Oct; 50(8):1491-7. PubMed ID: 6288215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.